Provided is a myostatin binding protein comprising CDRH3 with a defined sequence, comprising the motif RYYYGTGPADWYYDV. Antibodies based on the sequence can be used to treat diseases involving muscle mass, strength and function reduction, such as muscle-wasting, cancer, diabetes etc.